Namandje Bumpus
Director at Recursion Pharmaceuticals, Inc. (RXRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 3,963127,632 held (−3%) | $3.18 | $13K | +9.0% |
| Jun 4SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 4,38643,171 held (−9%) | $3.54 | $16K | -2.1% |
- Sell
Director Namandje Bumpus sold $13K of RXRX at $3.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Namandje Bumpus sold $16K of RXRX at $3.54 — pre-scheduled 10b5-1 plan sale.